Our studies.
Click on the buttons to view corresponding studies.
Knee Pain
Phase 2 clinical trial for treatment of chronic knee pain
DESCRIPTION
The purpose of this study is to examine the treatment of chronic knee pain through multiple interventions. This is an 8 week, placebo-controlled study that requires up to 10 in person visits to the clinic space.
ELIGIBILITY CRITERIA:
- must have a history pain in at least one knee for a minimum of 12 weeks
- age 40 years or older
- abstain from current pain medications
- if female, must be post-menopausal for at least one year or practicing an accepted, highly effective method of contraception or abstinence and plan to continue during the course of the study
- cannot have had back nerve block or surgery within last 6 months or cancer within the last 2 years
IRB NUMBER: STU00211998
LOCATION: 710 N. Lake Shore Dr. Abbott Hall Chicago, Il
CONTACT: Stephanie-Dee Sarovich
stephaniedee.sarovich@northwestern.edu, +1 312 503 4163
Clinical Trial for Treatment of Chronic Knee Pain through an Injection
DESCRIPTION
This study examines the effect of an injection on the relief of osteoarthritis of the knee. This study lasts for about 26 weeks and requires up to 8 visits to the study clinic.
ELIGIBILITY CRITERIA:
- must have a history pain in knee for greater than 6 months
- age 40-75
- cannot have had cancer less than 5 years ago
- cannot have had an injection less than 6 months ago
- cannot be allergic to hyaluronic acid or steroids
IRB NUMBER: STU00212272
LOCATION: 710 N. Lake Shore Dr. Abbott Hall Chicago, Il
CONTACT: Elizabeth Yan
elizabeth.yan@northwestern.edu, +1 312-503-6458
Diabetic Neuropathy
Phase 2 clinical trial with multiple interventions for the treatment of chronic pain from Diabetic Neuropathy
DESCRIPTION
This study aims to test the efficacious in relieving diabetic neuropathic pain. This is a 26 week placebo-controlled study. This study includes an 8 week treatment period and an 18 week follow up period.
ELIGIBILITY CRITERIA:
- must have a history of pain with diabetic neuropathy for a minimum of 6 months
- Type 1 or Type 2 diabetes with symmetrical foot pain
- age 18 years or older
- abstain from current pain medications
- if female, must be post-menopausal for at least one year or practicing an accepted, highly effective method of contraception or abstinence and plan to continue during the course of the study
- cannot have had back nerve block or surgery within last 6 months or cancer within the last 2 year
IRB NUMBER: STU00211998
LOCATION: 710 N. Lake Shore Dr. Abbott Hall Chicago, Il
CONTACT: Stephanie-Dee Sarovich
stephaniedee.sarovich@northwestern.edu, +1 312 503 4163
Back Pain
D-Cycloserine for the treatment of chronic, refractory low back pain
DESCRIPTION
The purpose of this study is to evaluate the efficacy and safety of D-cycloserine versus placebo in patients with lower back pain.
ELIGIBILITY CRITERIA:
- must have a history of low back pain for a minimum of 6 months
- age 18 years or older
- abstain from drinking alcohol during the course of the study
- if female, must be post-menopausal for at least one year or practicing an accepted, highly effective method of contraception or abstinence and plan to continue during the course of the study
IRB NUMBER: STU00205398
LOCATION: 710 N. Lake Shore Dr. Abbott Hall Chicago, Il
CONTACT: Chorine Adewale
chorine.adewale@northwestern.edu, +1 312 503 4651
Project 1, adaptations of the brain in chronic pain with opioid exposure
DESCRIPTION
Project One evaluates the effect of opioids on the brain in relation to chronic back pain. Through pain tracking, MRI scans, and various other methods, this study will look at understanding the effect of long-term opioid use on the chronic pain brain.
ELIGIBILITY CRITERIA:
- must have a history of back pain for a minimum of 6 months
- Must take prescribed opioids regularly
- age 18 years or older
- Must be in generally stable health
IRB NUMBER: STU00207384
LOCATION: 710 N. Lake Shore Dr. Abbott Hall Chicago, Il
CONTACT: Maryam Abdallah
maryam.abdallah@northwestern.edu, +1 312 503 4597
Phase 2 clinical trial with multiple interventions for the treatment of chronic back pain
DESCRIPTION
The purpose of this study is to examine the study drug to a placebo group on the treatment of chronic back pain. This is a 26 week long study with up to 10 visits to the clinic space. There is an 8 week treatment period and an 18 week follow up period.
ELIGIBILITY CRITERIA:
- must have a history of back pain for a minimum of 12 weeks
- age 18 years or older
- must be willing to abstain from current pain medications
- if female, must be post-menopausal for at least one year or practicing an accepted, highly effective method of contraception or abstinence and plan to continue during the course of the study
- Cannot have had back nerve block or surgery within last 6 months or cancer within the last 2 years
IRB NUMBER: STU00211998
LOCATION: 710 N. Lake Shore Dr. Abbott Hall Chicago, Il
CONTACT: Stephanie-Dee Sarovich
stephaniedee.sarovich@northwestern.edu, +1 312 503 4163
Bone Health
Effects of Romosozumab on bone health in women with spinal cord injury and osteoporosis
DESCRIPTION
Romosozumab is an FDA approved drug for osteoporosis in postmenopausal women. This study examines the effect of this drug in women with spinal cord injuries and osteoporosis.
ELIGIBILITY CRITERIA:
- spinal cord injury 6 or more months prior to enrollment
- 18 or older
- female
- diagnosis of osteoporosis